Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, ...

Michael Yee, Senior Biotech Analyst at Jefferies, appeared on CNBC to discuss how tariffs and policy risks are pressuring the ...

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2025 Earnings Call Transcript April 29, 2025 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.13, expectations were $-0.14.

China’s WuXi AppTec, which a US legislative commission called the “Huawei equivalent for biotechnology”, has reported a surge in US business despite increased scrutiny from Washington ...

Unity Biotechnology has a 1-year low of $0.85 and a 1-year high of $3.10. The company’s fifty day simple moving average is $1.33 and its 200-day simple moving average is $1.43.

Krystal Biotech (NASDAQ:KRYS) said that the European Commission granted marketing authorization to Vyjuvek for the treatment of wounds in certain patients with dystrophic epidermolysis bullosa ...

Investing.com -- Shares of Portage Biotech Inc (NASDAQ:PRTG) soared 33.9% in premarted trading following the announcement of confirmatory preclinical efficacy data for PORT-7, a potential new ...

The CEO of Novo Holdings has warned that his $160 billion fund will slow down investment activity until the dust settles after the Trump administration’s tariff blitz. Trump’s attack on global ...

VanEck Biotech ETF has a one year low of $135.34 and a one year high of $183.64. The firm has a market cap of $341.21 million, a P/E ratio of 31.41 and a beta of 0.82. VanEck Biotech ETF Company ...